Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

South San Francisco, California 94080


Purpose:

This is an observational study designed to follow patients with metastatic or locally advanced and unresectable colorectal cancer who are receiving Avastin in combination with chemotherapy and whose cancer has been either previously untreated or treated <=4 months prior to enrollment.


Criteria:

Inclusion Criteria: - Signed Informed Consent and Authorization document - Metastatic, or locally advanced and unresectable, adenocarcinoma of the colon or rectum - Receiving Avastin as a component of first-line chemotherapy - First-line chemotherapy plus Avastin initiated <=4 months prior to enrollment in the study Exclusion Criteria: - Patients who have contraindications for treatment with Avastin (see the Avastin Package Insert) or who would incur excessive risks with Avastin treatment are ineligible for this study.


NCT ID:

NCT00097578


Primary Contact:

Study Director
Eric Hedrick, M.D.
Genentech


Backup Contact:

N/A


Location Contact:

South San Francisco, California 94080
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.